QY Research, Inc.

Global Urinary Tract Infection Treatment Market Size, Status and Forecast 2018-2025

This report focuses on the global Urinary Tract Infection Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Urinary Tract Infection Treatment development in United States, Europe and China.

 

City of Industry, CA -- (SBWIRE) -- 08/25/2018 -- This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasing prevalence, the number of UTI increases, and thus, the high demand for drugs. Hence, increasing prevalence of diabetes worldwide is expected to act as a major driver for the global urinary tract infection therapeutics market.

The growing awareness of the controlled usage of antibiotics is one of the latest trends that gaining traction in the market. Antibiotic resistance leads to various other problems such as longer treatment regimens, longer hospitalizations, and increased side effects. This leads to the enormous burden on the healthcare system in terms of using significant economic and human resources.

EMEA is estimated to be the major revenue contributor to the market by 2023. UTIs have been a huge problem in the European Union (EU). Germany has the highest incidence of UTI among the five major EU countries; Germany, France, Italy, Spain, and the UK. The high mortality rate associated with the hospital-acquired UTI and antibiotic resistance to the infectious organisms are huge challenges for the region.

In 2017, the global Urinary Tract Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/674994/global-urinary-tract-infection-treatment-market

The key players covered in this study

Johnson & Johnson

Novartis

Pfizer

Merck

...

Market segment by Type, the product can be split into

Complicated UTI

Recurring Complicated UTI

Uncomplicated UTI

Neurogenic Bladder Infections

Others

Market segment by Application, split into

Hospital Pharmacies

Gynaecology and Urology Clinics

Drug Store

Retail Pharmacies

Online Drug Stores

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/f6fe494c6d3742fc012f069c28ccae7e,0,1

About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.